List of works by Per Pfeiffer

A Multidisciplinary Approach to the Treatment of Colorectal Liver Metastases Is Mandatory

journal article; published in Acta Radiologica in 2009

A nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors.

scientific article published on 28 October 2014

A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.

scientific article published in January 2015

A systematic review of observational studies of trifluridine/tipiracil (TAS-102) for metastatic colorectal cancer

scientific article published on 19 April 2019

A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy

scientific article published on 28 February 2014

AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin

scientific article published on 11 August 2015

Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer.

scientific article published on August 2010

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients - study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study

scientific article published on 12 June 2018

Adjuvant chemotherapy for patients with rectal cancer

scientific article published in September 2013

Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer.

scientific article published on 22 May 2013

Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines

scientific article published on December 2014

Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer.

scientific article published on 30 January 2018

Bevacizumab improves efficacy of trifluridine/tipiracil (TAS-102) in patients with chemorefractory metastatic colorectal cancer: a Danish randomized trial

scientific article published on 01 July 2019

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer

scientific article published on 01 May 2011

Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review

scientific article published on 10 February 2020

Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum.

scientific article published on 17 March 2011

Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. ⬇️

scientific article published on 28 December 2017

Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example

scientific article

Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil

scientific article published on 01 January 2007

Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients

scientific article published on 19 August 2012

Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies

scientific article published on 25 January 2014

Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?

scientific article published on 01 May 2015

Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil.

scientific article

Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy.

scientific article published on 24 October 2015

Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer

scientific article published on 11 November 2019

Comment on ESMO Magnitude of Clinical Benefit Scale

scientific article published on 14 September 2015

Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients

scientific article published on 09 May 2019

Current role of antibody therapy in patients with metastatic colorectal cancer.

scientific article published on May 2007

Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC)

scientific article published on 12 February 2019

Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between <i>DPYD</i>-genotype variants and P-uracil concentrations

scientific article published in 2022

Do we make progress in elderly patients with metastatic colorectal cancer?

scientific article published on 01 November 2018

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

scientific article published in April 1996

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

scientific article published on 01 October 2012

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

scientific article published on 5 July 2016

Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

scientific article published on 22 August 2016

Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy-induced polyneuropathy symptoms and signs

scientific article published on 02 August 2019

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

scientific article

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study

scientific article published on 01 April 2019

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

scientific article published on 30 September 2019

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

scientific article

Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version

scientific article published on 23 June 2020

Experience with S-1 in older Caucasian patients with metastatic colorectal cancer (mCRC): Findings from an observational chart review.

scientific article published on 16 May 2016

FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study.

scientific article published on 10 July 2014

Genetic studies in congenital anterior midline cervical cleft

scientific article published on 11 July 2012

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.

scientific article published on 11 August 2017

High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.

scientific article

High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial

scientific article published on 17 January 2012

Home parenteral nutrition increases fat free mass in patients with incurable gastrointestinal cancer. Results of a randomized controlled trial.

scientific article published on 21 December 2017

How to overcome resistance to therapy?

scientific article published on June 2012

How to select colorectal cancer patients for personalized therapy

scientific article published on 21 February 2019

In reply to Parlak and Topkan. Re: Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy.

scientific article

Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study

scientific article published on 29 February 2020

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab

scientific article published on 9 February 2015

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

scientific article published on 12 October 2016

Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancer

scientific article published on 04 June 2012

It's time to move forward in geriatric oncology.

scientific article published on 8 October 2015

Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study.

scientific article published on 13 November 2009

Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).

scientific article

Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer.

scientific article published on 10 May 2009

Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group.

scientific article

Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin

scientific article published on 21 June 2019

Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study

scientific article published on 26 November 2019

Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis

scientific article published on 10 January 2020

Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas

scientific article published on 29 June 2019

New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin

scientific article

New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer

scientific article published on 15 September 2010

Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence

scientific article published on 29 May 2019

Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).

scientific article published on 17 May 2017

Personalized Clinical Decision Making in Gastrointestinal Malignancies: The Role of PET.

scientific article published on 25 April 2016

Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer.

scientific article published on 29 April 2010

Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer

scientific article published on 01 January 2007

Phase II randomized clinical trial of endosonography and PET/CT versus clinical assessment only for follow-up after surgery for upper gastrointestinal cancer (EUFURO study)

scientific article published on 09 October 2019

Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysi

scientific article published on 01 June 2018

Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers

scientific article published on 21 October 2011

Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study

scientific article published on 02 April 2012

Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash.

scientific article published on 15 February 2017

Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer

scientific article published on 19 July 2010

Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study

scientific article published on 03 February 2014

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure

scientific article published on 27 November 2018

Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient

scientific article published on 29 August 2019

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study

scientific article published on 30 January 2020

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.

scientific article published on 17 July 2013

Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer

scientific article published on 04 November 2019

Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy

scientific article published on 13 December 2011

Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer

scientific article published on 06 January 2020

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome

scientific article published on 06 June 2018

Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis.

scientific article

Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results

scientific article published on 01 July 2019

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9.

scientific article

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

scientific article published on 07 March 2019

Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?

scientific article

Risk factors for brain metastases in patients with metastatic colorectal cancer.

scientific article published on 22 February 2017

S-1 (Teysuno) and gemcitabine in Caucasian patients with unresectable pancreatic adenocarcinoma

scientific article published on 31 January 2018

S-1 in combination with docetaxel and oxaliplatin in patients with advanced gastro-esophageal adenocarcinoma: two parallel phase 1/2a studies

scientific article published on 02 December 2016

Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.

scientific article published on 28 April 2018

Six cases of treatment with panitumumab in patients with severe hypersensitivity reactions to cetuximab.

scientific article published on 2 March 2009

Spatial and phenotypic characterization of pancreatic cancer-associated fibroblasts after neoadjuvant treatment

scientific article published on 21 January 2020

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer

scientific article published on 26 May 2016

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?

scientific article published on 07 August 2018

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial

scientific article published on 27 January 2020

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer

scientific article published on 08 August 2016

The changing face of treatment for metastatic colorectal cancer

scientific article published on 09 November 2018

The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study

scientific article published on 25 March 2019

The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer

scientific article published on 16 August 2016

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.

scientific article

Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients

scientific article published on 19 January 2017

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.

scientific article

Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer

scientific article published on 01 November 2018

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

scientific article published on 01 July 2019

Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC-OPC2

scientific article published on 09 June 2018

Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy

scientific article

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer

scientific article published on 13 November 2017

Trends in cancer in the elderly population in Denmark, 1980-2012.

scientific article

Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980-2012.

scientific article

Trends in colorectal cancer in the elderly in Denmark, 1980-2012.

scientific article

Trends in upper gastro-intestinal cancer among the elderly in Denmark, 1980-2012.

scientific article

Tumor-specific genetic aberrations in cell-free DNA of gastroesophageal cancer patients

scientific article published on 21 September 2018

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis

scientific article published on 17 January 2007

[Chemotherapy to patients with metastatic carcinoma of the esophagus and gastro-esophageal junction. A survey of a Cochrane review]

scientific article published on 01 February 2008

[Meningeal carcinomatosis in solid tumors]

scientific article published on 01 October 1995

[New treatment strategies for patients with primary non-resectable rectal cancer]

scientific article published on 01 May 2006

[Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of peritoneal metastases] ⬇️

scientific article published on 01 October 2019

[Tailored treatment to patients with metastatic colorectal cancer]

scientific article published on 01 March 2009

[Treatment of peritoneal carcinomatosis with pressurized intraperitoneal aerosol chemotherapy] ⬇️

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan

scientific article

miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells

scientific article

Paulina is supported by:

About Paulina

Help